Statement of Changes in Beneficial Ownership (4)
December 12 2022 - 06:21PM
Edgar (US Regulatory)
FORM 4
[ ] Check this box if no longer subject to Section
16. Form 4 or Form 5 obligations may continue. See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL
OWNERSHIP OF SECURITIES
|
OMB
APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5 |
|
Filed pursuant to Section 16(a) of the
Securities Exchange Act of 1934 or Section 30(h) of the Investment
Company Act of 1940
|
|
1. Name
and Address of Reporting Person * Kevane
Christopher E. |
2. Issuer Name and Ticker or Trading
Symbol UNIVERSAL TECHNICAL INSTITUTE INC [ UTI ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)_____
Director _____
10% Owner
__X__ Officer (give title
below) _____ Other
(specify below)
SVP Chief Legal Officer |
(Last)
(First)
(Middle)
4225 E. WINDROSE DRIVE, SUITE 200 |
3. Date of Earliest Transaction (MM/DD/YYYY)
12/8/2022
|
(Street)
PHOENIX, AZ 85032
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or
Beneficially Owned
|
1.Title of Security
(Instr. 3) |
2. Trans. Date |
2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following
Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) |
7. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
Amount |
(A) or (D) |
Price |
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible
securities)
|
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative
Security |
3. Trans. Date |
3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or
Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying
Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially
Owned Following Reported Transaction(s) (Instr. 4) |
10. Ownership Form of Derivative Security: Direct
(D) or Indirect (I) (Instr. 4) |
11. Nature of Indirect Beneficial Ownership (Instr.
4) |
Code |
V |
(A) |
(D) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Performance Units |
(1) |
12/8/2022 |
|
A |
|
39194 |
|
(1) |
(1) |
Common Stock, $0.0001 par
value |
39194.0 |
$0 |
116364 |
D |
|
Restricted Stock Units |
(2) |
12/8/2022 |
|
A |
|
25392 |
|
(3) |
(3) |
Common Stock, $0.0001 par
value |
25392.0 |
$0 |
56157 |
D |
|
Explanation of
Responses: |
(1) |
Each performance unit
represents a contingent right to receive one share of the UTI
Common Stock, 60% of which vest based on revenue for the fiscal
year ending September 30, 2025 and 40% of which vest based on
adjusted EBITDA for the fiscal year ending September 30, 2025, the
sum of which will be adjusted by a compound annual total
shareholder return ("TSR") modifier (which modifier may result in
the adjustment of the performance units by up to 25% either upward
or downward). For purposes of determining the TSR, the change in
the price of the UTI Common Stock is based upon the 30-trading day
average closing stock price (i) immediately preceding and through
grant date, and (ii) immediately preceding and through the 3rd
anniversary of grant date (ending price). The amount represents the
maximum number of shares that may be delivered pursuant to the
award, which is 187.5% of the target number of shares. |
(2) |
Each restricted stock unit
represents a contingent right to receive one share of Common
Stock. |
(3) |
The restricted stock units
vest in three equal annual installments beginning on December 8,
2023. |
Reporting
Owners
|
Reporting Owner Name / Address |
Relationships
|
Director |
10% Owner |
Officer |
Other |
Kevane Christopher E.
4225 E. WINDROSE DRIVE
SUITE 200
PHOENIX, AZ 85032 |
|
|
SVP Chief Legal Officer |
|
Signatures
|
/s/ Christopher E. Kevane |
|
12/12/2022 |
**Signature of
Reporting Person |
Date |
Reminder: Report on a separate line for each class
of securities beneficially owned directly or
indirectly. |
* |
If the form is filed by more than one
reporting person, see Instruction 4(b)(v). |
** |
Intentional misstatements or omissions
of facts constitute Federal Criminal Violations. See 18
U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: |
File three copies of this Form, one of
which must be manually signed. If space is insufficient, see
Instruction 6 for procedure. |
Persons who respond to the collection of information
contained in this form are not required to respond unless the form
displays a currently valid OMB control number. |
Universal Technical Inst... (NYSE:UTI)
Historical Stock Chart
From Feb 2023 to Mar 2023
Universal Technical Inst... (NYSE:UTI)
Historical Stock Chart
From Mar 2022 to Mar 2023